EUVIMEDEUVIMED entdecken
Crossref

Transition Metal (Molybdenum)-Doped Drug-like Conformational Nanoarchitectonics with Altered Valence States (Mn 2+ /Mn 4+ and Mo 5+ /Mo 6+ ) for Augmented Cancer Theranostics

Hong-Ying Xia, Ying Zhao, Ruo-Yin Meng, Ai-Zheng Chen iD, Shi-Bin Wang, Ranjith Kumar Kankala iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.4c00896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Hong-Ying Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, P. R. China. Hauptthemen laut MEDLINE: Molybdenum, Oxides, Manganese Compounds, Theranostic Nanomedicine. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: High-end Foreign Experts Recruitment Plan of China, Natural Science Foundation of Fujian Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the advancements in cancer therapy, delivering active pharmaceutical ingredients (APIs) using nanoparticles remains challenging due to the failed conveyance of the required drug payload, poor targeting ability, and poor biodistribution, hampering their clinical translation. Recently, the appropriate design of materials with intrinsic therapeutic functionalities has garnered enormous interest in the development of various intelligent therapeutic nanoplatforms. In this study, we demonstrate the fabrication of transition metal (molybdenum, Mo)-doped manganese dioxide (MnO2) nanoarchitectures, exhibiting diagnostic (magnetic resonance imaging, MRI) and therapeutic (chemodynamic therapy, CDT) functionalities. The facile hydrothermal approach-assisted Mo-doped MnO2 flower-like nanostructures offered tailorable morphologies in altered dimensions, precise therapeutic effects, exceptional biocompatibility, and biodegradability in the tumor microenvironment. The resultant defects due to doped Mo species exhibited peroxidase and oxidase activities, improving glutathione (GSH) oxidation. The two sets of variable valence metal ion pairs (Mn2+/Mn4+ and Mo5+/Mo6+) and their interplay could substantially improve the Fenton-like reaction and generate toxic hydroxyl radicals (•OH), thus achieving CDT-assisted antitumor effects. As inherent T1-MRI agents, these MnO2 nanoparticles displayed excellent MRI efficacy in vitro. Together, we believe that these conformational Mo-doped MnO2 nanoarchitectures with two pairs of variable valence states could potentiate drugless therapy in pharmaceutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MolybdenumOxidesManganese CompoundsTheranostic NanomedicineMagnetic Resonance ImagingHumansMiceAnimalsCell Line, TumorNeoplasmsNanoparticlesManganeseAntineoplastic AgentsTumor MicroenvironmentNanostructuresTissue Distribution

Stichwörter der Autor:innen

chemodynamic therapyconformational nanoarchitecturesdoping metalsglutathione oxidationmanganese dioxidemolybdenum

Substanzen

MolybdenumOxidesManganese Compoundsmanganese dioxideManganeseAntineoplastic Agents

Autor:innen und Institutionen

  • Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen 361021, P. R. China.
  • College of Chemical Engineering, Huaqiao University, Xiamen 361021, P. R. China.
  • Fujian Provincial Key Laboratory of Biochemical Technology (Huaqiao University), Xiamen 361021, P. R. China.

ORCID-Profile: Ai-Zheng Chen, Ranjith Kumar Kankala

Förderung

  • High-end Foreign Experts Recruitment Plan of China
  • Natural Science Foundation of Fujian Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Program for Innovation Research Team in Science and Technology in Fujian Province University

Zitieren

APA

Xia, H. Y., Zhao, Y., Meng, R. Y., Chen, A. Z., Wang, S. B., & Kankala, R. K. (2024). Transition Metal (Molybdenum)-Doped Drug-like Conformational Nanoarchitectonics with Altered Valence States (Mn 2+ /Mn 4+ and Mo 5+ /Mo 6+ ) for Augmented Cancer Theranostics. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00896

Vancouver

Xia HY, Zhao Y, Meng RY, Chen AZ, Wang SB, Kankala RK. Transition Metal (Molybdenum)-Doped Drug-like Conformational Nanoarchitectonics with Altered Valence States (Mn 2+ /Mn 4+ and Mo 5+ /Mo 6+ ) for Augmented Cancer Theranostics. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00896

BibTeX
@article{Xia2024,
  author = {Xia, Hong-Ying and Zhao, Ying and Meng, Ruo-Yin and Chen, Ai-Zheng and Wang, Shi-Bin and Kankala, Ranjith Kumar},
  title = {Transition Metal (Molybdenum)-Doped Drug-like Conformational Nanoarchitectonics with Altered Valence States (Mn 2+ /Mn 4+ and Mo 5+ /Mo 6+ ) for Augmented Cancer Theranostics},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.4c00896}
}
Kostenlos starten →